GSK-2878175
CAS No. 1423007-82-2
GSK-2878175 ( GSK2878175;GSK8175;GSK-175;GSK-175A )
产品货号. M11780 CAS No. 1423007-82-2
GSK-2878175 (GSK-175, GSK-175A) is a potent, pan-genotypic, second generation HCV NS5B polymerase inhibitor with EC50 of 0.4-9.7 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥14337 | 有现货 |
|
50MG | ¥28998 | 有现货 |
|
100MG | ¥39690 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK-2878175
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK-2878175 (GSK-175, GSK-175A) is a potent, pan-genotypic, second generation HCV NS5B polymerase inhibitor with EC50 of 0.4-9.7 nM.
-
产品描述GSK-2878175 (GSK-175, GSK-175A) is a potent, pan-genotypic, second generation HCV NS5B polymerase inhibitor with EC50 of 0.4-9.7 nM;exhibited low in vivo clearance across preclinical species and broad-spectrum activity against HCV replicons, displayed a 60-63 h half-life and a robust decrease in viral RNA levels in HCV infected patients relative to GSK5852.HCV Infection Phase 2 Clinical
-
同义词GSK2878175;GSK8175;GSK-175;GSK-175A
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCV
-
研究领域Infection
-
适应症HCV Infection
化学信息
-
CAS Number1423007-82-2
-
分子量568.81
-
分子式C27H23BClFN2O6S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(C1=C(C2=CC=C(F)C=C2)OC3=CC(N(C4=CC(Cl)=C5C(COB5O)=C4)S(=O)(C)=O)=C(C6CC6)C=C13)NC
-
化学全称6-[N-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)methanesulfonamido]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gardner SD, et al. J Viral Hepat. 2018 Jan;25(1):19-27.
2.Chong PY, et al. J Med Chem. 2019 Feb 14. doi: 10.1021/acs.jmedchem.8b01719.
2.Chong PY, et al. J Med Chem. 2019 Feb 14. doi: 10.1021/acs.jmedchem.8b01719.
产品手册
关联产品
-
PSI6206
PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor.
-
BLT-1
BLT-1 is a scavenger receptor BI (SR-BI)inhibitor.BLT-1 has IC50s of 60 and 110 nM for cellular DiI-HDL and [3H]CE-HDL uptake in ldlA[mSR-BI] cells.
-
IDX-17119
IDX-17119 is a potent, non-nucleoside, HCV NS5B RdRp inhibitor with IC50 of 0.4 nM in replicon luciferase assay.